Skip to main content
Clinical Trials/NCT04920461
NCT04920461UnknownNot Applicable

Visual-spatial and Visual-perceptual Disorders Following Cerebellar Strokes

Centre Hospitalier Universitaire de Besancon1 site in 1 country42 target enrollmentStarted: April 16, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
42
Locations
1
Primary Endpoint
Presence of Neuro-Visual Disorder

Study Overview

Brief Summary

This study aims at assessing the proportion of patients suffering from neuro-visual troubles (visual-spatial and/or visual-perceptual ), after cerebellar strokes.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Signed informed consent form
  • •Being able to pass initial neuropsychological tests within 10 days after stroke

Exclusion Criteria

  • •Previous central neural system/psychiatric/eye disease (including severe cranial trauma)
  • •Chronic alcoholism
  • •MRI contraindication.

Arms & Interventions

Additional MRI sequences

Experimental

Intervention: Additional MRI sequences (Device)

Additional MRI sequences

Experimental

Intervention: Neuropsychological assessment (Other)

Outcomes

Primary Outcomes

Presence of Neuro-Visual Disorder

Time Frame: Month 3

Presence of neuro-visual disorder will be confirmed by obtaining at least 2 pathological scores at following neuropsychological tests: * Rey \& Taylor figures (score from 0 to 36, maximum) * Judgment of Line Orientation (score from 0 to 36, maximum) * Weschler Adult Intelligence Scale (final score is intelligence quotient, with an average score is fixed at 100) * Test of Attentional Performance * Visual Object and Space Perception Battery (eight tests each designed to assess a particular aspect of object or space perception, while minimising the involvement of other cognitive skills) * Visual agnosia assesment protocole (noted on 10 points)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials